RayBiotech will leverage the reagents and technologies to expand its antibody-based products and services platforms.
The financial terms of the agreement were kept confidential.
Commenting on the license, RayBiotech president, COO and co-founder Rani Huang said, "Our original antibody array technology was developed by Emory researchers, and by continuing to work with Emory we have greatly expanded upon this original technology acquisition to further strengthen our portfolio of products and services."
Emory Office of Technology Transfer licensing associate Clifford Michaels said, "Adding RayBiotech to the growing number of research tool and reagent companies we work with will allow for even wider distribution and dissemination of these valuable and important tools."